Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Milich

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of General Virology|January 21, 2003
Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependentUna Lazdina, Mats Alheim, Jessica Nyström, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 25, 2011
Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccinationAntony Chen, Gustaf Ahlén, Erwin D Brenndörfer, et al.
The Journal of Infectious Diseases|May 8, 2010
Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytesJessica Nyström, Antony Chen, Lars Frelin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Interaction of the hepatitis B core antigen and the innate immune systemByung O Lee, Amy Tucker, Lars Frelin, et al.
Plos One|May 2, 2015
P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage InfectionsDavid C Whitacre, Diego A Espinosa, Cory J Peters, et al.
The Journal of General Virology|May 23, 2001
Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant proteinUna Lazdina, Catharina Hultgren, Lars Frelin, et al.
Journal of Virology|November 14, 2008
A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infectionLars Frelin, Therese Wahlström, Amy E Tucker, et al.
The Journal of Clinical Investigation|March 10, 2015
Palivizumab epitope-displaying virus-like particles protect rodents from RSV challengeJeanne H Schickli, David C Whitacre, Roderick S Tang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of General Virology|January 21, 2003
Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependentUna Lazdina, Mats Alheim, Jessica Nyström, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 25, 2011
Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccinationAntony Chen, Gustaf Ahlén, Erwin D Brenndörfer, et al.
The Journal of Infectious Diseases|May 8, 2010
Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytesJessica Nyström, Antony Chen, Lars Frelin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
Interaction of the hepatitis B core antigen and the innate immune systemByung O Lee, Amy Tucker, Lars Frelin, et al.
Plos One|May 2, 2015
P. falciparum and P. vivax Epitope-Focused VLPs Elicit Sterile Immunity to Blood Stage InfectionsDavid C Whitacre, Diego A Espinosa, Cory J Peters, et al.
The Journal of General Virology|May 23, 2001
Humoral and CD4(+) T helper (Th) cell responses to the hepatitis C virus non-structural 3 (NS3) protein: NS3 primes Th1-like responses more effectively as a DNA-based immunogen than as a recombinant proteinUna Lazdina, Catharina Hultgren, Lars Frelin, et al.
Journal of Virology|November 14, 2008
A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infectionLars Frelin, Therese Wahlström, Amy E Tucker, et al.
The Journal of Clinical Investigation|March 10, 2015
Palivizumab epitope-displaying virus-like particles protect rodents from RSV challengeJeanne H Schickli, David C Whitacre, Roderick S Tang, et al.
Pageof 2